The Licensing Department, in cooperation with the Regulatory Affairs Department, are engaged in the out-licensing of Medochemie's product dossiers, which aim to establish new, strategic contractual partnerships with other pharmaceutical companies in a market.
Our customers include the largest multinational generic companies as well as numerous local companies. In recent years, Medochemie has licensed out several product dossiers to customers in Western Europe, Canada, Australia, New Zealand and South Africa, with our products already registered on behalf of customers in 29 countries.
We have an impressive track record of maintaining partnerships beyond the expiration of contractual obligations, which demonstrates our customers’ high satisfaction levels with our products and services as well as our competitive prices.